Clinical trial
Randomized, Dose-finding, Double-blind, Placebo-controlled, Crossover Gluten Challenge Trial in Subjects With Nonceliac Gluten-sensitivity
NCT03188367 is registered in ClinicalTrials.gov with Antonio Di Sabatino as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Dose-finding, Double-blind, Placebo-controlled, Crossover Gluten Challenge Trial in Subjects With Nonceliac Gluten-sensitivity
- Lead sponsor
- Antonio Di Sabatino
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 13, 2017
- Completion date
- December 13, 2020
- Enrollment
- 840 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nonceliac gluten sensitivity